Solubilisierung stark lipophiler Arzneistoffe in lipidhaltige ...

Literaturverzeichnis
84. Wacher, V. J., Salphati, L., und Benet, L. Z., Active secretion and enterocytic drug metabolism
barriers to drug absorption, Adv. Drug Deliv. Rev. 46 (2001) 89-102.
85. Benet, L. Z., Izumi, T., Zhang, Y., Silverman, J. A., und Wacher, V. J., Intestinal MDR transport
proteins and P-450 enzymes as barriers to oral drug delivery, J. Contr. Release 62 (1999) 25-31.
86. Suzuki, H. und Sugiyama, Y., Role of metabolic enzymes and efflux transporters in the absorption
of drugs from the small intestine, Eur. J. Pharm. Sci. 12 (2000) 3-12.
87. Bretschneider, B., Brandsch, M., und Neubert, R., Intestinal transport of beta-lactam antibiotics:
analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell
monolayers and the transepithelial flux, Pharm. Res. 16 (1999) 55-61.
88. Peters, W. H., Allebes, W. A., Jansen, P. L., Poels, L. G., und Capel, P. J., Characterization and
tissue specificity of a monoclonal antibody against human uridine 5'-diphosphate-glucuronosyltransferase,
Gastroenterology 93 (1987) 162-169.
89. Wynalda, M. A., Hutzler, J. M., Koets, M. D., Podoll, T., und Wienkers, L. C., In vitro metabolism
of clindamycin in human liver and intestinal microsomes, Drug Metab. Dispos. 31 (2003) 878-
887.
90. Obach, R. S., Zhang, Q. Y., Dunbar, D., und Kaminsky, L. S., Metabolic characterization of the
major human small intestinal cytochrome p450s, Drug Metab. Dispos. 29 (2001) 347-352.
91. Emoto, C., Yamazaki, H., Iketaki, H., Yamasaki, S., Satoh, T., Shimizu, R., Suzuki, S., Shimada,
N., Nakajima, M., und Yokoi, T., Cooperativity of alpha-naphthoflavone in cytochrome P450 3Adependent
drug oxidation activities in hepatic and intestinal microsomes from mouse and human,
Xenobiotica 31 (2001) 265-275.
92. Yamamoto, T., Hagima, N., Nakamura, M., Kohno, Y., Nagata, K., und Yamazoe, Y., Differences
in cytochrome P450 forms involved in the metabolism of N,N-dipropyl-2-[4-methoxy-3-(2phenylethoxy)phenyl]ethylamine
monohydrochloride (NE-100), a novel sigma ligand, in human
liver and intestine, Drug Metab. Dispos. 31 (2003) 60-66.
93. Chiba, M., Hensleigh, M., und Lin, J. H., Hepatic and intestinal metabolism of indinavir, an HIV
protease inhibitor, in rat and human microsomes. Major role of CYP3A, Biochem. Pharmacol. 53
(1997) 1187-1195.
94. Johnson, T. N., Tanner, M. S., Taylor, C. J., und Tucker, G. T., Enterocytic CYP3A4 in a
paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis,
Br. J. Clin. Pharmacol. 51 (2001) 451-460.
95. Ungell, A.-L., Ex vivo models for studying intestinal transport. A lecture in the 4 th International
Intensive Course and Workshop on Cell Culture and in-vitro Models for Drug Absorption and
Delivery (20 Feb.-1 Mar./2002), Universität Saarland, Saarbrücken, DE, (unveröffentlichte Arbeit).
96. Takemoto, K., Yamazaki, H., Tanaka, Y., Nakajima, M., und Yokoi, T., Catalytic activities of
cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat
everted sacs and intestinal microsomes, Xenobiotica 33 (2003) 43-55.
97. Wortelboer, H. M., van der Linden, E. C., De Kruif, C. A., Noordhoek, J., Blaauboer, B. J., van
Bladeren, P. J., und Falke, H. E., Effects of indole-3-carbinol on biotransformation enzymes in the
rat: in vivo changes in liver and small intestinal mucosa in comparison with primary hepatocyte
cultures, Food Chem. Toxicol. 30 (1992) 589-599.
98. Milewich, L., MacDonald, P. C., und Carr, B. R., Activity of 17 beta-hydroxysteroid oxidoreductase
in tissues of the human fetus, J. Endocrinol. 123 (1989) 509-518.
99. Farthing, M. J., Vinson, G. P., Edwards, C. R., und Dawson, A. M., 17 beta-Hydroxysteroid
dehydrogenase activity in the mucosa of rat and human small intestine, J. Steroid Biochem. 14
(1981) 1107-1113.
100. Sano, T., Hirasawa, G., Takeyama, J., Darnel, A. D., Suzuki, T., Moriya, T., Kato, K., Sekine, H.,
Ohara, S., Shimosegawa, T., Nakamura, J., Yoshihama, M., Harada, N., und Sasano, H., 17 beta-
Hydroxysteroid dehydrogenase type 2 expression and enzyme activity in the human gastrointestinal
tract, Clin. Sci. (Lond) 101 (2001) 485-491.
cxiii